Corient Capital Partners, LLC Novartis Ag Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,708 shares of NVS stock, worth $606,532. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,708

Previous 5,392 5.86%

Holding current value

$606,532

Previous $455,000 5.93%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $23,576 - $27,574	316 Added 5.86%	5,708 $482,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $19,485 - $22,687	-242 Reduced 4.3%	5,392 $455,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $115,598 - $130,764	1,443 Added 34.43%	5,634 $494,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $544,908 - $602,544	-6,837 Reduced 62.0%	4,191 $366,000
Q3 2021 Nov 16, 2021	BUY	$81.78 - $95.14 $35,328 - $41,100	432 Added 4.08%	11,028 $902,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $114,562 - $126,537	1,344 Added 14.53%	10,596 $967,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $69,555 - $82,025	833 Added 9.89%	9,252 $791,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $249,980 - $302,364	-3,202 Reduced 27.55%	8,419 $795,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $18,481 - $20,475	225 Added 1.97%	11,621 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $5,422 - $6,103	67 Added 0.59%	11,396 $995,000
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $303,668 - $425,445	-4,297 Reduced 27.5%	11,329 $934,000
Q4 2019 Feb 04, 2020	SELL	$84.35 - $95.37 $49,935 - $56,459	-592 Reduced 3.65%	15,626 $1.48 Million
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $78,782 - $86,813	-921 Reduced 5.37%	16,218 $1.41 Million
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $32,195 - $39,625	-427 Reduced 2.43%	17,139 $1.57 Million
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $40,371 - $46,176	-536 Reduced 2.96%	17,566 $1.69 Million
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $100,324 - $111,711	1,362 Added 8.14%	18,102 $1.55 Million
Q2 2018 Oct 02, 2018	BUY	$64.91 - $73.36 $133,844 - $151,268	2,062 Added 14.05%	16,740 $1.27 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $285,994 - $341,901	4,063 Added 38.28%	14,678 $1.19 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $56,779 - $60,947	-785 Reduced 6.89%	10,615 $891,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $15,421 - $16,072	-208 Reduced 1.79%	11,400 $0
Q2 2017 Aug 14, 2017	BUY	N/A	299 Added 2.64%	11,608 $969,000
Q1 2017 Aug 17, 2017	SELL	N/A	-53,780 Reduced 82.63%	11,309 $840,000
Q1 2017 Aug 14, 2017	BUY	N/A	65,089	65,089 $5.91 Million

Others Institutions Holding NVS

# of Institutions

1,439

Shares Held

135M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Novartis Ag Transaction History